Heidi
Category: AI in Healthcare
An AI-powered clinical care partner platform that automates medical documentation, provides real-time evidence-based clinical decision support, and manages patient communications. Heidi was founded in 2019. The company is led by Dr. Thomas Kelly. Based in Melbourne, Australia. Team size: 200-250. Total funding raised: $96.6M. Latest round: Series B. Key investors include Point72 Private Investments, Blackbird Ventures, Headline, Latitude, Anthology, Local Globe.
- Founded
- 2019
- Headquarters
- Melbourne, Australia
- Team size
- 200-250
- Total funding
- $96.6M
Value proposition
Saves clinicians 2.5+ hours daily by automating clinical documentation and providing ad-free evidence-based clinical decision support.
Products and solutions
Heidi AI Scribe, Heidi Evidence, Heidi Comms, Heidi Remote, EHR Integration Platform
Unique value
Combines ambient AI clinical documentation with an ad-free, commercially-unbiased evidence layer. Supports 110+ languages and offers free individual clinician access.
Target customer
Healthcare clinicians, health systems, NHS trusts, and medical practice organizations.
Industries served
Healthcare Technology, Clinical Documentation, Healthcare AI, Electronic Health Records (EHR)
Technology advantage
Leverages Anthropic's Claude models for complex clinical conversation interpretation. Proprietary adaptive voice recognition. Largest deployment of ambient AI in UK healthcare.
How they differentiate
Model-agnostic AI architecture with ad-free, commercially-unbiased clinical evidence layer. Supports 110+ languages and offers free individual clinician access.
Main competitors
Abridge, Ambience Healthcare, Nuance/Microsoft Dragon Ambient Experience (DAX)
Key partnerships
Anthropic, HealthPathways, EMGuidance, MIMS, NICE, BMJ Group, Modality Partnership, NHS Trusts, AutoMedica, R1 RCM
Notable customers
Modality Partnership, Cambridge University Hospitals NHS Foundation Trust, NHS Trusts (North West London Acute Provider Collaborative), Beth Israel Lahey Health, MaineGeneral
Major milestones
Series A extension ($16.6M USD) led by Headline in March 2025, Largest ambient AI deployment in UK healthcare via Modality Partnership (January 2025), Series B ($65M USD) led by Point72 at $465M valuation (October 2025), Acquisition of AutoMedica (February 2026), Strategic partnership with R1 RCM (March 2026), Launch of Heidi Remote hardware device (March 2026), Epic integration expanded to mobile with Haiku support (March 2026)
Growth metrics
Supports 2.5M+ weekly consultations across 190+ countries, 115M+ clinical interactions globally, saved 18M+ clinician hours in 18 months. Valued at $465M post-Series B.
Market positioning
Global challenger in AI medical scribe market with strong foothold in UK/NHS and rapid expansion in North America.
Geographic focus
Global presence across 190+ countries with primary markets in UK, Australia, United States, Canada, and Europe.
Patents and IP
No registered patents publicly disclosed as of latest update (February 2026)
About Dr. Thomas Kelly
Dr. Thomas Kelly is a vascular surgical resident and medical doctor who left clinical practice to found Heidi Health. He holds a Medical Degree from the University of Melbourne. He was recognized in Becker's Health IT & Revenue Cycle Up-and-Comers list for 2025 and led the company through a $65M Series B in 2025.
Official website: https://www.heidihealth.com